Key result
In a 37-year-old woman with peripartum cardiomyopathy, emergency cesarean section and bromocriptine administration improved left ventricular ejection fraction from 29.7% to 57.6% after one month.
Case Report (n=1)
No
Bromocriptine administration combined with intensive perioperative management successfully improved left ventricular function in a severe case of peripartum cardiomyopathy.
Does not support routine bromocriptine use; leaves open efficacy in peripartum cardiomyopathy pending controlled trials.
周産期心筋症（peripartum cardiomyopathy：PPCM）は周産期に重症な心不全を引き起こす予後不良の疾患であるが，速やかに診断，治療を行うことで母児の予後改善が期待できる．また，近年その病態が少しずつ明らかになってきており，従来から行われている心不全に対する治療に加え，ブロモクリプチン投与による心機能改善が報告されている．今回，妊娠高血圧症候群を合併し，妊娠33週に発症した周産期心筋症に対し，厳重な周術期管理およびブロモクリプチン投与を行い心機能の改善を得られた症例を経験した．
No takes yet. Share an insight, caveat, or question.
YOMO et al. (2011) conducted a case report in Peripartum cardiomyopathy complicated by severe heart failure (n=1). Emergency cesarean section and bromocriptine was evaluated on Left ventricular ejection fraction (EF). In a 37-year-old woman with peripartum cardiomyopathy, emergency cesarean section and bromocriptine administration improved left ventricular ejection fraction from 29.7% to 57.6% after one month.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: